Thyroid microcarcinoma during thyroidectomy

Singapore Medical Journal

Volumn 49, Issue 1, 2008, Pages 23-25

  Siassakos, D ^a   Gourgiotis, Stavros ^b,c   Moustafellos, P ^b   Dimopoulos, N ^b   Hadjiyannakis, E ^b  

^a Southmead University Hospital   (United Kingdom)

^b EVANGELISMOS HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Thyroid carcinoma; Thyroid microcarcinoma; Thyroidectomy

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GREECE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLOMA; PREVALENCE; THYROID CARCINOMA; THYROIDECTOMY;

BIOPSY, NEEDLE; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HASHIMOTO DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; MEDICAL ONCOLOGY; RISK; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 39049138304     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13:381-7.
2. Arem R, Padayatty SJ, Saliby AH, Sherman SI. Thyroid microcarcinoma: prevalence, prognosis, and management. Endocr Pract 1999; 5:148-56.
3. Biscolla RP, Ugolini C, Sculli M, et al. Medullary and papillary tumours are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behaviour. Thyroid 2004; 14:946-52.
4. Carlini M, Giovannini C, Castaldi F, et al. High risk for microcarcinoma in thyroid benign diseases. Incidence in a one year period of total thyroidectomies. J Exp Clin Cancer Res 2005; 24:231-6.
5. Dietlein M, Luyken WA, Schicha H, Larena-Avellaneda A. Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough? Nucl Med Commun 2005; 26:3-8.
6. Kovács GL, Gonda G, Vadász G, et al. Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 2005; 15:152-7.
7. Neuhold N, Kaiser H, Kaserer K. Latent carcinoma of the thyroid in Austria: a systematic autopsy study. Endocr Pathol 2001; 12:23-31.
8. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systemic autopsy study. Cancer 1985; 56:531-8.
9. Furlan JC, Rosen IB. Prognostic relevance of previous exposure to ionizing radiation in well-differentiated thyroid cancer. Langenbecks Arch Surg 2004; 389:198-203.
10. Tzavara I, Vlassopoulou B, Alevizaki C, et al. Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece. Clin Endocrinol (Oxf) 1999; 50:643-54.
11. Vigneri R, Pezzino V, Squatrito S, et al. Iodine deficiency and thyroid cancer. In: Delange F, Robertson A, McLoughney E, Gerasimov G, eds. Elimination of Iodine Deficiency Disorders (IDD) in Central and Eastern Europe, the Commonwealth of Independent States, and the Baltic States. Geneva: WHO, 1998: 67-72.
12. Verkooijen HM, Fioretta G, Pache JC, et al. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 2003; 14:13-7.
13. Baloch ZW, LiVolsi VA. Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med 2000; 124:1192-5.
14. Lucas-Martin A, Foz-Salam, Todd I, Bottazzo GF, Pujol-Borrell R. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. J Clin Endocrinol Metab 1988; 66:367-75.
15. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992; 112:1139-46.
16. Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 1998; 22:731-7.
17. Yang GC, LiVolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up. Int J Surg Pathol 2002; 10:133-9.
18. Khoo ML, Ezzat S, Freeman JL, Asa SL. Cyclin D1 expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab 2002; 87:1810-3.
19. Pilotti S, Collini P, Manzari A, Marubini E, Rilke F. Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol 1995; 12:249-55.
20. Albores-Saavedra JA, Krueger JE. C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol 2001; 12:365-77.
21. Guyétant S, Dupre F, Bigorgne JC, et al. Medullary thyroid microcarcinoma: a clinicopathological retrospective study of 38 patients with no prior familial disease. Hum Pathol 1999; 30:957-63.